Collectively, these findings suggest a role for tumor cell-intrinsic and -extrinsic STAT3 signaling in regulating anti-tumor immunity via expression of checkpoint molecules and represent a promising strategy to improve the efficacy of immune checkpoint inhibitors. Here, STAT3 is linked to neoplasm.